CK 2289 is an inhibitor of type III cyclic 3'5' -adenosinemonophosphate phosphodiesterase with potential use in the treatment of congestive heart failure.
Indimilast is used to inhibit phosphodiesterase IV that regulates lung inflammation and causes bronchiectasis by increasing intracellular cyclicadenosine 3', 5'-monophosphate in airway smooth muscle and inflammatory cells. Potential to treat chronic obst
Kushenol A is a kind of Adenosine 3', 5'-cyclicmonophosphate(cAMP)phosphodiesterase inhibitiors, it shows selective alpha-glucosidase inhibitory activity. Kushenol A and kushenol C exhibit inhibitory activity against Sodium-dependent glucose cotransporter 2(SGLT2).
VIP(6-28)(human, rat, porcine, bovine) is a potent antagonist that effectively counteracts the effects of exogenous vasoactive intestinal peptide (VIP) on cyclicadenosinemonophosphate (cAMP) signaling.
Licoarylcoumarin is a strong inhibitor of adenosine 3',5'-cyclicmonophosphate (cAMP) phosphodiesterase. Licoarylcoumarin has antibacterial effects on the VRE strains; it has anti-HIV activity, and it has inhibitory effects on xanthine oxidase.